HIF1A predicts the efficacy of anti-PD-1 therapy in advanced clear cell renal cell carcinoma

Immunotherapy for cancer has become a revolutionary treatment, with the progress of immunological research on cancer. Cancer patients have also become more diversified in drug selection. Individualized medical care of patients is more important in the era of precision medicine. For advanced clear ce...

Descripción completa

Detalles Bibliográficos
Autores principales: Guo, Tuanjie, Wang, Tao, Zhang, Jian, Chen, Siteng, Wang, Xiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Neoplasia Press 2022
Materias:
Perspective
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9530654/
https://www.ncbi.nlm.nih.gov/pubmed/36191462
http://dx.doi.org/10.1016/j.tranon.2022.101554

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9530654/
https://www.ncbi.nlm.nih.gov/pubmed/36191462
http://dx.doi.org/10.1016/j.tranon.2022.101554

Ejemplares similares